Donor-specific circulating cell free DNA as a noninvasive biomarker of graft injury in heart transplantation.

CONCLUSION: These results suggest that cfDNA monitoring of transplanted patients may be a useful tool to detect and probably anticipate graft rejection.
PMID: 31175849 [PubMed - as supplied by publisher]

Source: International Journal of Clinical Chemistry - June 4, 2019 Category: Chemistry Authors: Macher HC, García-Fernández N, Adsuar-Gómez A, Porras-López M, González-Calle A, Noval-Padillo J, Guerrero JM, Molinero P, Borrego-Domínguez JM, Herruzo-Avilés Á, Rubio A Tags: Clin Chim Acta Source Type: research